163 related articles for article (PubMed ID: 17102983)
1. A null mutation in VAMP1/synaptobrevin is associated with neurological defects and prewean mortality in the lethal-wasting mouse mutant.
Nystuen AM; Schwendinger JK; Sachs AJ; Yang AW; Haider NB
Neurogenetics; 2007 Jan; 8(1):1-10. PubMed ID: 17102983
[TBL] [Abstract][Full Text] [Related]
2. Gene network of a phosphoglycerate mutase in muscle wasting in mice.
Wang L; Jiao Y; Sun S; Jarrett HW; Sun D; Gu W
Cell Biol Int; 2015 Jun; 39(6):666-77. PubMed ID: 25644094
[TBL] [Abstract][Full Text] [Related]
3. An insertion of intracisternal A-particle retrotransposon in a novel member of the phosphoglycerate mutase family in the lew allele of mutant mice.
Jiao Y; Jin X; Yan J; Jiao F; Li X; Roe BA; Jarrett HW; Gu W
Genes Genet Syst; 2009 Oct; 84(5):327-34. PubMed ID: 20154419
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel Vamp1 splice variant in the cochlear nucleus.
Friedland DR; Eernisse R; Popper P
Hear Res; 2008 Sep; 243(1-2):105-12. PubMed ID: 18655825
[TBL] [Abstract][Full Text] [Related]
5. Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.
Sevlever D; Zou F; Ma L; Carrasquillo S; Crump MG; Culley OJ; Hunter TA; Bisceglio GD; Younkin L; Allen M; Carrasquillo MM; Sando SB; Aasly JO; Dickson DW; Graff-Radford NR; Petersen RC; Deák F; ; Belbin O
Mol Neurodegener; 2015 Apr; 10():18. PubMed ID: 25881291
[TBL] [Abstract][Full Text] [Related]
6. The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction.
Liu Y; Sugiura Y; Lin W
J Physiol; 2011 Apr; 589(Pt 7):1603-18. PubMed ID: 21282288
[TBL] [Abstract][Full Text] [Related]
7. Distribution of synaptobrevin/VAMP 1 and 2 in rat brain.
Raptis A; Torrejón-Escribano B; Gómez de Aranda I; Blasi J
J Chem Neuroanat; 2005 Dec; 30(4):201-11. PubMed ID: 16169186
[TBL] [Abstract][Full Text] [Related]
8. VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families.
Bourassa CV; Meijer IA; Merner ND; Grewal KK; Stefanelli MG; Hodgkinson K; Ives EJ; Pryse-Phillips W; Jog M; Boycott K; Grimes DA; Goobie S; Leckey R; Dion PA; Rouleau GA
Am J Hum Genet; 2012 Sep; 91(3):548-52. PubMed ID: 22958904
[TBL] [Abstract][Full Text] [Related]
9. Distribution of SNAP25, VAMP1 and VAMP2 in mature and developing deep cerebellar nuclei after estrogen administration.
Manca P; Mameli O; Caria MA; Torrejón-Escribano B; Blasi J
Neuroscience; 2014 Apr; 266():102-15. PubMed ID: 24534378
[TBL] [Abstract][Full Text] [Related]
10. SCNM1, a putative RNA splicing factor that modifies disease severity in mice.
Buchner DA; Trudeau M; Meisler MH
Science; 2003 Aug; 301(5635):967-9. PubMed ID: 12920299
[TBL] [Abstract][Full Text] [Related]
11. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.
Salpietro V; Lin W; Delle Vedove A; Storbeck M; Liu Y; Efthymiou S; Manole A; Wiethoff S; Ye Q; Saggar A; McElreavey K; Krishnakumar SS; ; Pitt M; Bello OD; Rothman JE; Basel-Vanagaite L; Hubshman MW; Aharoni S; Manzur AY; Wirth B; Houlden H
Ann Neurol; 2017 Apr; 81(4):597-603. PubMed ID: 28253535
[TBL] [Abstract][Full Text] [Related]
12. Cloning, genomic structure, and expression profiles of TULIP1 (GARNL1), a brain-expressed candidate gene for 14q13-linked neurological phenotypes, and its murine homologue.
Schwarzbraun T; Vincent JB; Schumacher A; Geschwind DH; Oliveira J; Windpassinger C; Ofner L; Ledinegg MK; Kroisel PM; Wagner K; Petek E
Genomics; 2004 Sep; 84(3):577-86. PubMed ID: 15498464
[TBL] [Abstract][Full Text] [Related]
13. Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13.
Buchner DA; Seburn KL; Frankel WN; Meisler MH
Mamm Genome; 2004 May; 15(5):344-51. PubMed ID: 15170223
[TBL] [Abstract][Full Text] [Related]
14. Synaptobrevin 1 mediates vesicle priming and evoked release in a subpopulation of hippocampal neurons.
Zimmermann J; Trimbuch T; Rosenmund C
J Neurophysiol; 2014 Sep; 112(6):1559-65. PubMed ID: 24944211
[TBL] [Abstract][Full Text] [Related]
15. SNAP-25 regulation during adrenal gland development: comparison with differentiation markers and other SNAREs.
Hepp R; Grant NJ; Aunis D; Langley K
J Comp Neurol; 2000 Jun; 421(4):533-42. PubMed ID: 10842212
[TBL] [Abstract][Full Text] [Related]
16. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
Freeman W; Morton AJ
Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
[TBL] [Abstract][Full Text] [Related]
17. Vesicle associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activation-induced degranulation of mature human mast cells.
Sander LE; Frank SP; Bolat S; Blank U; Galli T; Bigalke H; Bischoff SC; Lorentz A
Eur J Immunol; 2008 Mar; 38(3):855-63. PubMed ID: 18253931
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation.
Wycisk KA; Budde B; Feil S; Skosyrski S; Buzzi F; Neidhardt J; Glaus E; Nürnberg P; Ruether K; Berger W
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3523-30. PubMed ID: 16877424
[TBL] [Abstract][Full Text] [Related]
19. Selective reduction in synaptic proteins involved in vesicle docking and signalling at synapses in the ataxic mutant mouse stargazer.
Leitch B; Shevtsova O; Kerr JR
J Comp Neurol; 2009 Jan; 512(1):52-73. PubMed ID: 18972569
[TBL] [Abstract][Full Text] [Related]
20. Identification, localization and interaction of SNARE proteins in atrial cardiac myocytes.
Peters CG; Miller DF; Giovannucci DR
J Mol Cell Cardiol; 2006 Mar; 40(3):361-74. PubMed ID: 16458920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
